SCHEMBL30599166

SCHEMBL30599166

FCOc1cnnc(Cl)c1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25397218 1.00 CYP11B2 (0.31) CYP11B2
SCHEMBL29056486 0.79 MAPT (0.43) CYP11B2
SCHEMBL750505 0.76 PLAU (0.37)
SCHEMBL29244376 0.76 NPC1 (0.46)
SCHEMBL21055345 0.73 ALOX5 (0.46)
SCHEMBL2211310 0.72
SCHEMBL30698349 0.72
SCHEMBL31312440 0.72 RXRA (0.32)
SCHEMBL25393018 0.72 RXRA (0.32)
SCHEMBL30904782 0.71 NPC1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4486722-A2 COMPOUNDS, COMPOSITIONS, AND METHODS Nico Therapeutics, Inc. (US) 2025-01-08 EP disclosed
CN-119137101-A Compounds, compositions, and methods 尼科治疗有限公司 2024-12-13 CN disclosed
WO-2023168298-A2 COMPOUNDS, COMPOSITIONS, AND METHODS DENALI THERAPEUTICS INC. (US) 2023-09-07 WO disclosed